ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $177,256 | 0.0% | 111,482 | 0.0% | 0.00% | – |
Q1 2023 | $177,256 | -60.3% | 111,482 | +55.5% | 0.00% | – |
Q4 2022 | $446,660 | -99.9% | 71,695 | +114.2% | 0.00% | – |
Q3 2021 | $403,385,000 | -43.0% | 33,476 | 0.0% | 0.00% | – |
Q2 2021 | $708,017,000 | -7.3% | 33,476 | +22.9% | 0.00% | – |
Q1 2021 | $763,970,000 | +27.7% | 27,236 | +18.4% | 0.00% | – |
Q4 2020 | $598,026,000 | -30.1% | 23,001 | 0.0% | 0.00% | – |
Q3 2020 | $854,947,000 | -28.2% | 23,001 | -0.9% | 0.00% | -100.0% |
Q2 2020 | $1,190,803,000 | +95.6% | 23,208 | +20.2% | 0.00% | – |
Q1 2020 | $608,655,000 | -51.8% | 19,304 | -8.8% | 0.00% | -100.0% |
Q4 2019 | $1,262,367,000 | +63.3% | 21,170 | +0.4% | 0.00% | 0.0% |
Q3 2019 | $772,866,000 | -5.0% | 21,082 | +20.6% | 0.00% | 0.0% |
Q2 2019 | $813,541,000 | +35.2% | 17,488 | +16.7% | 0.00% | – |
Q1 2019 | $601,849,000 | -5.8% | 14,990 | +7.9% | 0.00% | -100.0% |
Q4 2018 | $639,078,000 | +53.2% | 13,893 | +47.8% | 0.00% | – |
Q3 2018 | $417,078,000 | +74.5% | 9,400 | +54.1% | 0.00% | – |
Q2 2018 | $239,059,000 | -95.1% | 6,100 | -90.9% | 0.00% | -100.0% |
Q1 2018 | $4,829,764,000 | +12.3% | 66,774 | +2.3% | 0.00% | 0.0% |
Q4 2017 | $4,298,957,000 | +115.0% | 65,294 | +63.7% | 0.00% | +100.0% |
Q3 2017 | $1,999,688,000 | +10.2% | 39,898 | +1.8% | 0.00% | 0.0% |
Q2 2017 | $1,814,083,000 | -72.5% | 39,198 | -79.1% | 0.00% | -71.4% |
Q1 2017 | $6,608,337,000 | +1417998.1% | 187,152 | +3183.4% | 0.01% | – |
Q2 2015 | $466,000 | +22.6% | 5,700 | +39.0% | 0.00% | – |
Q1 2015 | $380,000 | – | 4,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |